USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
A Ripe Business Opportunity for Big Pharma and Generic Pharma Companies
The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and branded) as well as therapeutic areas (anti-infectives, cardiovascular, diabetes, oncology, respiratory, and CNS). This study provides a detailed analysis that includes market overview, market engineering measurements, revenue forecasts, competitive analysis, and key trends for the pharmaceutical industry in Ghana and Nigeria.
Key Findings
Key Findings (continued)
Scope and Segmentation
Market Segmentation
Market Segmentation (continued)
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Executive Summary—Three Big Predictions
Market Segmentation
Market Segmentation (continued)
Segmentation by Tiers of Competition
Segmentation by Tiers of Competition (continued)
New Market Opportunities
New Market Opportunities (continued)
Key Merger, Acquisition, and Partnership Assessment
Key Merger, Acquisition, and Partnership Assessment (continued)
Market Drivers
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Market Restraints
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Market Impact of Key Drivers and Restraints
Market Engineering Measurements
Forecast Assumptions and Definitions
Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Per Cent Revenue Forecast by Region
Revenue Forecast by Region
Ghana & Nigeria—Therapeutic Segment Growth Analysis
Procurement Process
Ghanaian Pharmaceutical Industry Overview
Ghanaian Pharmaceutical Industry Overview (continued)
Ghana—Health Profile
Ghana—Malaria
Ghana—Malaria (continued)
Ghana—Malaria (continued)
Ghana—Tuberculosis (TB)/HIV
Ghana—Tuberculosis (TB)/HIV (continued)
Ghana—Tuberculosis (TB)/HIV (continued)
Ghana—Non-communicable Diseases (NCDs)
Ghana—Non-communicable Diseases (continued)
Ghana—Non-communicable Diseases (continued)
Ghana—Non-communicable Diseases (continued)
Ghanaian Pharmaceutical Industry
Ghanaian Pharmaceutical Industry—Market Engineering Measurements
Ghanaian Pharmaceutical Industry—Revenue Forecast
Ghanaian Pharmaceutical Industry—Revenue Forecast Discussion
Ghanaian Pharmaceutical Industry—Revenue Forecast Discussion (continued)
Ghana—Per Cent Revenue Forecast by Product Segment
Ghana—Per Cent Revenue Forecast by Therapeutic Segment
OTC Pharmaceuticals Segment—Revenue Forecast
OTC Pharmaceuticals Segment—Revenue Forecast Discussion
Generic Pharmaceuticals Segment—Revenue Forecast
Generic Pharmaceuticals Segment—Revenue Forecast Discussion
Branded Pharmaceuticals Segment—Revenue Forecast
Branded Pharmaceuticals Segment—Revenue Forecast Discussion
Anti-infectives Segment—Revenue Forecast
Anti-infectives Segment—Revenue Forecast Discussion
Anti-infectives Segment—Revenue Forecast Discussion (continued)
Anti-infectives Segment—Revenue Forecast Discussion (continued)
Cardiovascular Segment—Revenue Forecast
Cardiovascular Segment—Revenue Forecast Discussion
Diabetes Segment—Revenue Forecast
Diabetes Segment—Revenue Forecast Discussion
Respiratory Segment—Revenue Forecast
Respiratory Segment—Revenue Forecast Discussion
CNS Segment—Revenue Forecast
CNS Segment—Revenue Forecast Discussion
Oncology Segment—Revenue Forecast
Oncology Segment—Revenue Forecast Discussion
Pricing Analysis
Pricing Analysis (continued)
Pricing Analysis (continued)
Ghanaian Pharmaceutical Industry—SWOT Analysis
PESTLE Analysis
Regulatory Analysis
Ghanaian Pharmaceutical Industry—Procurement and Supply Management
Ghanaian Pharmaceutical Industry—Procurement and Supply Management (continued)
Ghanaian Pharmaceutical Industry—Distribution
Ghanaian Pharmaceutical Industry—Distribution (continued)
Ghanaian Pharmaceutical Industry—Retail
Ghanaian Pharmaceutical Industry—Demand Analysis
Ghanaian Pharmaceutical Industry—Demand Analysis (continued)
Competitive Environment
Competitive Environment (continued)
Ghanaian Pharmaceutical Industry—Competitor AnalysisMultinationals
Ghanaian Pharmaceutical Industry—Competitor AnalysisGeneric Companies
Ghanaian Pharmaceutical Industry—Competitor AnalysisLocal Manufacturers
Ghanaian Pharmaceutical Industry—Competitor ProfileErnest Chemists Limited
Ghanaian Pharmaceutical Industry—Competitor ProfileKinapharma Limited
Ghanaian Pharmaceutical Industry—Competitor ProfilePhyto-Riker (GIHOC) Pharmaceutical Limited
Ghanaian Pharmaceutical Industry—Competitor ProfileAyrton Drugs Manufacturing Company Limited
Ghanaian Pharmaceutical Industry—Competitor ProfileKama Group Limited
Nigerian Pharmaceutical Industry Overview
Nigerian Pharmaceutical Industry Overview (continued)
Nigeria—Health Profile
Nigeria—Malaria
Nigeria—Malaria (continued)
Nigeria—Malaria (continued)
Nigeria—Tuberculosis (TB)/HIV
Nigeria—Tuberculosis (TB)/HIV (continued)
Nigeria—Tuberculosis (TB)/HIV (continued)
Nigeria—Non-communicable Diseases (NCDs)
Nigeria—Non-communicable Diseases (continued)
Nigeria—Non-communicable Diseases (continued)
Nigeria—Non-communicable Diseases (continued)
Nigerian Pharmaceutical Industry
Nigerian Pharmaceutical Industry—Market Engineering Measurements
Nigerian Pharmaceutical Industry—Revenue Forecast
Nigerian Pharmaceutical Industry—Revenue Forecast Discussion
Nigerian Pharmaceutical Industry—Revenue Forecast Discussion (continued)
Nigeria—Per Cent Revenue Forecast by Product Segment
Nigeria—Per Cent Revenue Forecast by Product and Therapeutic Segment
OTC Pharmaceuticals Segment—Revenue Forecast
OTC Pharmaceuticals Segment—Revenue Forecast Discussion
Generic Pharmaceuticals Segment—Revenue Forecast
Generic Pharmaceuticals Segment—Revenue Forecast Discussion
Branded Pharmaceuticals Segment—Revenue Forecast
Branded Pharmaceuticals Segment—Revenue Forecast Discussion
Anti-infectives Segment—Revenue Forecast
Anti-infectives Segment—Revenue Forecast Discussion
Anti-infectives Segment Revenue—Forecast Discussion (continued)
Anti-infectives Segment—Revenue Forecast Discussion (continued)
Cardiovascular Segment—Revenue Forecast
Cardiovascular Segment—Revenue Forecast Discussion
Diabetes Segment—Revenue Forecast
Diabetes Segment—Revenue Forecast Discussion
Respiratory Segment—Revenue Forecast
Respiratory Segment—Revenue Forecast Discussion
CNS Segment—Revenue Forecast
CNS Segment—Revenue Forecast Discussion
Oncology Segment—Revenue Forecast
Oncology Segment—Revenue Forecast Discussion
Pricing Analysis
Pricing Analysis (continued)
Nigerian Pharmaceutical Industry—SWOT Analysis
PESTLE Analysis
Regulatory Analysis
Regulatory Analysis (continued)
Nigerian Pharmaceutical Industry—Procurement and Supply Management
Nigerian Pharmaceutical Industry—Procurement and Supply Management (continued)
Nigerian Pharmaceutical Industry—Distribution
Nigerian Pharmaceutical Industry—Distribution (continued)
Nigerian Pharmaceutical Industry—Demand Analysis
Ghanaian Pharmaceutical Industry—Demand Analysis (continued)
Ghanaian Pharmaceutical Industry—Demand Analysis (continued)
Competitive Environment
Competitive Environment (continued)
Nigerian Pharmaceutical Industry—Competitor AnalysisMultinationals
Nigerian Pharmaceutical Industry—Competitor AnalysisGeneric Companies
Nigerian Pharmaceutical Industry—Competitor AnalysisLocal Manufacturers
Nigerian Pharmaceutical Industry—Competitor ProfileEmzor Pharmaceutical Industries Limited
Nigerian Pharmaceutical Industry—Competitor ProfileFidson Healthcare PLC
Nigerian Pharmaceutical Industry—Competitor ProfileMay & Baker Nigeria PLC
Nigerian Pharmaceutical Industry—Competitor ProfileEvans Medical PLC
Nigerian Pharmaceutical Industry—Competitor ProfileNigeria German Chemicals PLC
Key Companies to Watch
The Last Word—Three Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
Legal Disclaimer
Market Background
Important Market Metrics
Market Landscape and Pricing
Decision Support Database—Total Healthcare Expenditure
Decision Support Database—Total Healthcare Expenditure (continued)
Decision Support Database—Public Healthcare Expenditure
Decision Support Database—Public Healthcare Expenditure (continued)
Decision Support Database—Private Healthcare Expenditure
Decision Support Database—Private Healthcare Expenditure (continued)
Other Related Research Services
List of Other Key Companies Included in this Research Service
Market Engineering Methodology
Learn More—Next Steps
Speak directly with our analytics experts for tailored recommendations.
Recent related industry research
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: Facility Management in Malaysia, 2026
Malaysia's facility management (FM) market is transitioning from labor-intensive, compliance-driven service delivery to technology-enabled, outcome-oriented, and sustainability-integrated operating models. Competitive differentiation increasingly depends on providers’ ability to combine integrated F...
17 Sep 2026 | Global | Market Research
Growth Opportunities in the Western Europe Consumer eSIM Market, 2026–2029
The consumer eSIM market in Western Europe is growing steadily, supported by the rising availability of eSIM-capable devices, particularly smartphones, and expanding travel-related use cases. However, commercialization has yet to translate into mass adoption. Despite Apple’s global launch of an eSIM...
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: ASEAN Warehouse Automation System Providers, 2026
Warehouse automation has moved from a discretionary capital project to a core operating capability. ASEAN operators are redesigning fulfillment networks around smaller orders, shorter delivery windows, broader stock keeping unit (SKU) ranges, and sharper demand volatility. Manual operations remain v...
16 Sep 2026 | North America | Customer Research
US Automotive Technicians’ Choice Survey, 2025
The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...
16 Sep 2026 | Global | Market Research
Apple Performance Tracker, Q1 2026
This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aiswariya Chidambaram |
| WIP Number | MA49-01-00-00-00 |
| Keyword 1 | pharmaceutical industry in ghana |
| Keyword 2 | pharmaceutical industry in Nigeria |
| Keyword 3 | pharmaceutical in Nigeria |
| Is Prebook | No |